Table 3.
Adjusted hazard ratio | 95% confidence interval | P value | |
---|---|---|---|
Male | 2.75 | 0.55 –13.79 | 0.218 |
Age | 1.07 | 0.99 – 1.15 | 0.103 |
Comorbidity | |||
Human immunodeficiency virus infection | - | - | - |
Chronic obstructive pulmonary disease | - | - | - |
Connective tissue disease | 0.33 | 0.04- 2.78 | 0.309 |
Silicosis | - | - | - |
Diabetes mellitus | 2.81 | 0.62 – 12.75 | 0.180 |
End stage renal disease | - | - | - |
Malignancy | 1.78 | 0.20 – 15.69 | 0.602 |
Liver disease | |||
Non-alcoholic liver cirrhosis | 0.97 | 0.11–8.46 | 0.976 |
Alcoholic liver cirrhosis | - | - | - |
Other alcoholic liver disease | - | - | - |
Liver disease severity | |||
Ascites | - | - | - |
Esophageal varices | - | - | - |
Hepatic encephalopathy | 54.90 | 2.82–1069.53 | *0.008 |
Interferon-based therapy | 2.81 | 0.61–12.98 | 0.185 |
*means P < 0.05.